Related references
Note: Only part of the references are listed.Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test
Antonin Bal et al.
CLINICAL CHEMISTRY (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
M. J. Joyner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Emergency response for evaluating SARS-CoV-2 immune status, seroprevalence and convalescent plasma in Argentina
Diego S. Ojeda et al.
PLOS PATHOGENS (2021)
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Leonidas Stamatatos et al.
SCIENCE (2021)
SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
Dung Nguyen et al.
EUROSURVEILLANCE (2021)
Assessment of serological assays for identifying high titer convalescent plasma
Christopher W. Farnsworth et al.
TRANSFUSION (2021)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors
Pierre Gallian et al.
ANTIVIRAL RESEARCH (2020)
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays
Mei San Tang et al.
CLINICAL CHEMISTRY (2020)
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
Sabra Klein et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma
Yasmin Maor et al.
ECLINICALMEDICINE (2020)